Scarica l'app Stockscreener
14.33
1.27%
0.18
Precedente Chiudi:
$14.15
Aprire:
$14.35
Volume 24 ore:
280.07K
Relative Volume:
0.77
Capitalizzazione di mercato:
$481.40M
Reddito:
-
Utile/perdita netta:
$-47.20M
Rapporto P/E:
-9.1548
EPS:
-1.5653
Flusso di cassa netto:
$-43.65M
1 W Prestazione:
-2.62%
1M Prestazione:
+22.48%
6M Prestazione:
+31.71%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$13.91
$15.04
Intervallo di 1 settimana:
$12.86
$15.04
Portata 52W:
$4.8069
$27.50
Mbx Biosciences Inc Stock (MBX) Company Profile
Nome
Mbx Biosciences Inc
Settore
Industria
Telefono
(317) 989-3100
Indirizzo
11711 N. MERIDIAN STREET, CARMEL
Confronta MBX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MBX
Mbx Biosciences Inc
|
14.33 | 489.46M | 0 | -47.20M | -43.65M | -1.5653 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Mbx Biosciences Inc Stock (MBX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-15 | Ripresa | Jefferies | Buy |
| 2025-08-05 | Iniziato | Mizuho | Outperform |
| 2025-07-16 | Iniziato | Oppenheimer | Outperform |
| 2025-04-10 | Iniziato | Citizens JMP | Mkt Outperform |
| 2024-10-08 | Iniziato | Guggenheim | Buy |
| 2024-10-08 | Iniziato | JP Morgan | Overweight |
| 2024-10-08 | Iniziato | Jefferies | Buy |
| 2024-10-08 | Iniziato | Stifel | Buy |
Mostra tutto
Mbx Biosciences Inc Borsa (MBX) Ultime notizie
MBX Biosciences Insiders Added US$579.8k Of Stock To Their Holdings - Yahoo Finance
Screener Results Flag MBX Biosciences Inc. as OversoldTrade Risk Summary & Long-Term Growth Portfolio Plans - mustnews.co.kr
MBX Biosciences Submits IND for Once-Monthly Obesity Drug - MSN
Forecasting MBX Biosciences Inc. price range with options dataBear Alert & Daily Entry Point Trade Alerts - Newser
How to recover losses in MBX Biosciences Inc. stockTrade Volume Summary & Accurate Trade Setup Notifications - Newser
Volume Profile Shows Strong Base for MBX Biosciences Inc.July 2025 Trends & Capital Efficient Trade Techniques - thegnnews.com
Can swing trading help recover from MBX Biosciences Inc. lossesWeekly Trade Report & Smart Investment Allocation Tips - Newser
Breakout Traders Target MBX Biosciences Inc. on Recovery SetupWeekly Profit Report & Stock Portfolio Risk Management - newsimpact.co.kr
What to do if you’re stuck in MBX Biosciences Inc.July 2025 Macro Moves & Free Technical Pattern Based Buy Signals - Newser
What makes MBX Biosciences Inc. stock price move sharplyTrade Volume Summary & Weekly Market Pulse Alerts - thegnnews.com
Is MBX Biosciences Inc. a strong growth stock2025 Geopolitical Influence & Accurate Buy Signal Notifications - thegnnews.com
MBX Biosciences Inc. recovery potential after sell offPortfolio Update Summary & Reliable Entry Point Trade Alerts - Newser
How to track smart money flows in MBX Biosciences Inc.Take Profit & Risk Adjusted Buy and Sell Alerts - Newser
Can a trend reversal in MBX Biosciences Inc. lead to recovery2025 Market Overview & Fast Moving Stock Watchlists - Newser
MBX Biosciences stock rating initiated at Buy by Jefferies with $36 target - Investing.com
When is the best time to exit MBX Biosciences Inc.2025 Winners & Losers & Safe Swing Trade Setup Alerts - Newser
Jefferies Maintains "Buy" Rating for MBX Biosciences with $36 Price Target. - AInvest
What is MBX Biosciences Inc.’s book value per share2025 Historical Comparison & Long-Term Growth Stock Strategies - thegnnews.com
MBX Biosciences assumed with a Buy at Jefferies - TipRanks
MBX Biosciences (MBX) and Its Competitors Critical Survey - Defense World
Published on: 2025-08-14 21:34:07 - Newser
Options Data Show Bullish Bias in MBX Biosciences Inc.July 2025 Price Swings & Expert Verified Stock Movement Alerts - kangso.co.kr
What’s next for MBX Biosciences Inc. stock priceJuly 2025 Price Swings & Weekly Hot Stock Watchlists - Newser
How to use a screener to detect MBX Biosciences Inc. breakoutsJuly 2025 Gainers & Weekly Breakout Opportunity Watchlist - Newser
MBX Biosciences (MBX) and The Competition Head to Head Survey - Defense World
Is MBX Biosciences Inc. stock a good hedge against inflationBear Alert & Detailed Earnings Play Strategies - Newser
Can volume confirm reversal in MBX Biosciences Inc.Market Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Volatility clustering patterns for MBX Biosciences Inc.July 2025 Highlights & Free Risk Controlled Daily Trade Plans - Newser
Applying big data sentiment scoring on MBX Biosciences Inc.Weekly Loss Report & Weekly High Return Forecasts - Newser
MBX Biosciences, Inc. (NYSE:MBX) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Can trapped investors hope for a rebound in MBX Biosciences Inc. [2025 Trading Recap]Free Daily Stock Trend Watchlist - Newser
MBX Biosciences Triggers Bullish KDJ Golden Cross and Marubozu - AInvest
Using economic indicators to assess MBX Biosciences Inc. potentialSector-Wise Equity Performance Trend Forecast - Newser
MBX Biosciences Reports Progress and Financial Stability - TipRanks
Tools to assess MBX Biosciences Inc.’s risk profileTriple Digit Gain Opportunity Watchlist - Newser
Technical signs of recovery in MBX Biosciences Inc.Free Reliable Investment Entry Point Signals - Newser
Can trapped investors hope for a rebound in MBX Biosciences Inc.Free Market Surge Signal for Swing Traders - Newser
How does MBX Biosciences Inc. compare to its peers3x ROI Investment Watch - thegnnews.com
MBX Biosciences (NYSE:MBX) Earns Outperform Rating from Analysts at Mizuho - MarketBeat
Technical analysis overview for MBX Biosciences Inc. stockMachine Learning Intraday Signal Forecast - Newser
Is MBX Biosciences Inc. forming a reversal patternSwing Trade Picks with High Potential - Newser
Mbx Biosciences Inc Azioni (MBX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Mbx Biosciences Inc Azioni (MBX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| GORDON CARL L | Director |
Feb 18 '25 |
Buy |
10.84 |
143,170 |
1,551,963 |
3,255,000 |
| GORDON CARL L | Director |
Feb 14 '25 |
Buy |
9.87 |
47,502 |
468,793 |
3,205,930 |
| ORBIMED ADVISORS LLC | Director |
Feb 18 '25 |
Buy |
10.84 |
143,170 |
1,551,963 |
3,255,000 |
| ORBIMED ADVISORS LLC | Director |
Feb 14 '25 |
Buy |
9.87 |
47,502 |
468,793 |
3,205,930 |
| Hawryluk P. Kent | President & CEO |
Feb 04 '25 |
Buy |
10.69 |
50,000 |
534,500 |
448,277 |
| Mathers Edward T | Director |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
| BASKETT FOREST | 10% Owner |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
| Behbahani Ali | 10% Owner |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
| Chang Carmen | 10% Owner |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
| Florence Anthony A. Jr. | 10% Owner |
Sep 16 '24 |
Buy |
16.00 |
500,000 |
8,000,000 |
3,614,486 |
0.94%
1.72%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):